Twist Bioscience Corporation (TWST) DCF Valuation

Twist Bioscience Corporation (TWST) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Twist Bioscience Corporation (TWST) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our Twist Bioscience Corporation (TWST) DCF Calculator enables you to assess the valuation of Twist Bioscience Corporation using real-world financial data while providing complete flexibility to modify all essential parameters for enhanced projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 90.1 132.3 203.6 245.1 313.0 429.4 589.1 808.3 1,109.0 1,521.5
Revenue Growth, % 0 46.87 53.83 20.41 27.69 37.2 37.2 37.2 37.2 37.2
EBITDA -132.1 -143.9 -191.6 -174.2 -176.7 -362.1 -496.8 -681.6 -935.1 -1,282.9
EBITDA, % -146.6 -108.75 -94.1 -71.05 -56.46 -84.32 -84.32 -84.32 -84.32 -84.32
Depreciation 6.7 12.0 36.6 29.3 31.4 48.5 66.5 91.3 125.3 171.8
Depreciation, % 7.41 9.06 18 11.96 10.04 11.29 11.29 11.29 11.29 11.29
EBIT -138.8 -155.9 -228.2 -203.5 -208.1 -386.0 -529.6 -726.7 -997.0 -1,367.9
EBIT, % -154.01 -117.81 -112.1 -83.01 -66.5 -89.9 -89.9 -89.9 -89.9 -89.9
Total Cash 290.0 477.9 505.0 336.4 276.4 419.4 575.4 789.4 1,083.0 1,485.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 26.4 28.5 40.3 44.1 34.9
Account Receivables, % 29.27 21.57 19.79 17.98 11.15
Inventories 12.3 31.8 39.3 32.1 24.1 66.8 91.6 125.7 172.5 236.6
Inventories, % 13.64 24.03 19.31 13.08 7.69 15.55 15.55 15.55 15.55 15.55
Accounts Payable 4.8 14.9 20.1 14.1 1.6 28.1 38.6 52.9 72.6 99.6
Accounts Payable, % 5.36 11.26 9.87 5.73 0.52081 6.55 6.55 6.55 6.55 6.55
Capital Expenditure -9.9 -27.1 -101.9 -27.8 -5.1 -81.1 -111.2 -152.6 -209.4 -287.2
Capital Expenditure, % -10.95 -20.45 -50.04 -11.33 -1.62 -18.88 -18.88 -18.88 -18.88 -18.88
Tax Rate, % -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902
EBITAT -139.1 -154.0 -217.8 -204.6 -208.7 -381.6 -523.5 -718.2 -985.4 -1,351.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -176.2 -180.6 -297.1 -205.6 -177.6 -481.1 -614.4 -843.0 -1,156.6 -1,586.8
WACC, % 12.61 12.61 12.6 12.61 12.61 12.61 12.61 12.61 12.61 12.61
PV UFCF
SUM PV UFCF -3,097.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1,619
Terminal Value -15,260
Present Terminal Value -8,428
Enterprise Value -11,526
Net Debt -141
Equity Value -11,385
Diluted Shares Outstanding, MM 58
Equity Value Per Share -196.23

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to generate various scenarios.
  • Real-World Data: Twist Bioscience Corporation’s (TWST) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life TWST Financials: Pre-filled historical and projected data for Twist Bioscience Corporation (TWST).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Twist's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Twist's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Twist Bioscience Corporation’s preloaded data.
  • 2. Modify Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV for (TWST).
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
  • 5. Present with Confidence: Share professional valuation insights to bolster your decision-making process.

Why Choose This Calculator for Twist Bioscience (TWST)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for biotech investments.
  • Flexible Inputs: Modify the highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Twist Bioscience’s intrinsic value and Net Present Value.
  • Preloaded Information: Access historical and projected data for reliable analysis.
  • Expert Level: Perfect for financial professionals, investors, and biotech consultants.

Who Should Use Twist Bioscience Corporation (TWST)?

  • Biotech Investors: Leverage advanced tools to make informed investment choices in the biotech sector.
  • Research Scientists: Access high-quality DNA synthesis services for your innovative projects.
  • Pharmaceutical Consultants: Quickly tailor solutions for clients in drug development and genomics.
  • Biotechnology Enthusiasts: Enhance your knowledge of synthetic biology and its applications through real-world case studies.
  • Educators and Students: Utilize it as a hands-on resource in biotechnology and life sciences curricula.

What the Template Contains

  • Pre-Filled DCF Model: Twist Bioscience’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Twist Bioscience’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.